Association of common comorbidities with osteonecrosis: a nationwide population-based case–control study in Denmark

Objective To examine recent time trends in the incidence of osteonecrosis (ON) in Denmark and to investigate different common comorbidities association with ON in a population-based setting. Methods Using Danish medical databases, we included all patients with a first-time hospital diagnosis of ON during 1995–2012. Each ON case was matched with 10 randomly selected population control subjects from general population. For all participants, we obtained a complete hospital history of comorbidities included in the CharlsonComorbidity Index 5 years preceding the inclusion date. Results 4107 ON cases and 41 063 controls were included. The incidence of ON increased from 3.9 in 1995 to 5.5 in 2012 per 100 000 inhabitants. Solid cancer was the most common comorbidity, associated with an adjusted OR (aOR) for ON of 2.0 (95% CI 1.7 to 2.2). For advanced metastatic cancer, leukaemia and lymphoma, aORs of ON were 3.4 (95% CI 2.5 to 4.5), 4.3 (95% CI 2.7 to 7.0) and 5.8 (95% CI 4.3 to 7.8), respectively. Among other chronic conditions, aORs were 3.5 (95% CI 3.0 to 4.1) for connective tissue diseases and 2.3 (95% CI 2.0 to 2.7) for chronic pulmonary diseases. aORs were also increased at 2.8 (95% CI 1.9 to 4.1) and 4.5 (95% CI 2.5 to 8.2) for mild and moderate-to-severe liver disease, respectively, and 4.2 (95% CI 3.4 to 5.2) for renal disease. Conclusion This large population-based study provides evidence for an increasing ON incidence in the general population and documents an association between several common comorbid conditions and risk of ON.

[1]  L. Pedersen,et al.  Risk of osteonecrosis in patients with systemic lupus erythematosus: A nationwide population-based study. , 2016, European journal of internal medicine.

[2]  H. Sørensen,et al.  Evaluation of an ICD‐10 algorithm to detect osteonecrosis of the jaw among cancer patients in the Danish National Registry of Patients , 2015, Pharmacoepidemiology and drug safety.

[3]  T. Kubo,et al.  Temporal Trends in Characteristics of Newly Diagnosed Nontraumatic Osteonecrosis of the Femoral Head From 1997 to 2011: A Hospital-Based Sentinel Monitoring System in Japan , 2015, Journal of epidemiology.

[4]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[5]  H. Kim,et al.  Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome , 2014, Lupus.

[6]  C. Y. Lim,et al.  Various musculoskeletal manifestations of chronic renal insufficiency. , 2013, Clinical radiology.

[7]  H. Sørensen,et al.  Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs , 2013, Clinical epidemiology.

[8]  T. Kubo,et al.  The effect of alcohol intake and the use of oral corticosteroids on the risk of idiopathic osteonecrosis of the femoral head: a case-control study in Japan. , 2013, The bone & joint journal.

[9]  Anna P. Joseph,et al.  Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review , 2012, Journal of oral and maxillofacial pathology : JOMFP.

[10]  S. Kishida,et al.  Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. , 2011, Rheumatology.

[11]  Y. Iwamoto,et al.  Incidence of nontraumatic osteonecrosis of the femoral head in the Japanese population. , 2011, Arthritis and rheumatism.

[12]  Timothy L Lash,et al.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.

[13]  J. Hallas,et al.  Increased use of inhaled corticosteroids among young Danish adult asthmatics: an observational study. , 2010, Respiratory medicine.

[14]  T. Kubo,et al.  Nationwide Epidemiologic Survey of Idiopathic Osteonecrosis of the Femoral Head , 2010, Clinical orthopaedics and related research.

[15]  S. Bhatia,et al.  Predictors of avascular necrosis of bone in long‐term survivors of hematopoietic cell transplantation , 2009, Cancer.

[16]  C. Cooper,et al.  The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK , 2009, Osteoporosis International.

[17]  A. Karantanas,et al.  Osteonecrosis of the femoral head: etiology, imaging and treatment. , 2007, European journal of radiology.

[18]  E. Bonfá,et al.  Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus , 2007, Lupus.

[19]  David S Hungerford,et al.  Nontraumatic osteonecrosis of the femoral head: ten years later. , 2006, The Journal of bone and joint surgery. American volume.

[20]  Abraham Schneider,et al.  Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Ahn,et al.  A Case of Avascular Necrosis of the Femoral Head as Initial Presentation of Chronic Myelogenous Leukemia , 2005, The Korean journal of internal medicine.

[22]  A. Ahuja,et al.  Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. , 2005, Radiology.

[23]  Yoshiatsu Tanaka.  [Corticosteroid therapy for nephrotic syndrome]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[24]  T. Ogura,et al.  Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation , 2003, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[25]  Y. Chao,et al.  Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. , 2003, Alcohol and alcoholism.

[26]  W. Jaffe,et al.  Osteonecrosis of the femoral head. , 2003, MedGenMed : Medscape general medicine.

[27]  M. Bostrom,et al.  Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management , 2003, AIDS.

[28]  Y. Shoenfeld,et al.  Pathogenesis and natural history of osteonecrosis. , 2002, Seminars in arthritis and rheumatism.

[29]  R. Davey,et al.  High Prevalence of Osteonecrosis of the Femoral Head in HIV-Infected Adults , 2002, Annals of Internal Medicine.

[30]  H. Iwata,et al.  Osteonecrosis of the Femoral Head After Allogeneic Bone Marrow Transplantation , 2001, Clinical orthopaedics and related research.

[31]  D. Hungerford,et al.  Atraumatic osteonecrosis of the humeral head. , 2000, The Journal of rheumatology.

[32]  C. Colwell,et al.  Osteonecrosis of the femoral head in patients with inflammatory arthritis or asthma receiving corticosteroid therapy. , 1996, Orthopedics.

[33]  Ken Fukuda,et al.  Flushing pattern and idiopathic avascular necrosis of the femoral head. , 1996, Journal of epidemiology.

[34]  M. Mori,et al.  Association of alcohol intake, cigarette smoking, and occupational status with the risk of idiopathic osteonecrosis of the femoral head. , 1993, American journal of epidemiology.

[35]  H. Mankin,et al.  Nontraumatic necrosis of bone (osteonecrosis). , 1992, The New England journal of medicine.

[36]  Y. Sugioka,et al.  Influence of Alcohol Intake, Cigarette Smoking, and Occupational Status on Idiopathic Osteonecrosis of the Femoral Head , 1988, Clinical orthopaedics and related research.

[37]  R. Wilson,et al.  Aseptic Necrosis in the Femur after Renal Transplantation , 1972, Annals of surgery.

[38]  J. Gardeniers,et al.  The Prevalence of Osteonecrosis in Different Parts of the World , 2014 .

[39]  T. Yamashita,et al.  High risk of osteonecrosis of the femoral head in autoimmune disease patients showing no immediate increase in hepatic enzyme under steroid therapy , 2011, Rheumatology International.

[40]  E. Winquist,et al.  Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours , 2008, Drug safety.

[41]  K. Sullivan,et al.  Avascular necrosis following bone marrow transplantation: a case-control study. , 1998, Bone.